Michael A. Palladino

Author

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

M A Palladino, M Palladino, M. A. PALLADINO, M. A. Palladino, M. PALLADINO, M. Palladino, M.A Palladino, M.A. Palladino, MA Palladino, MICHAEL A. PALLADINO

304

Publications

22.4K

Citations

H-Index

175

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center New York University Dana-Farber Cancer Institute Monmouth University Harvard University

About

Michael A. Palladino is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	82	14.5K
2	Allergy	10	11	1.7K
3	Natural Sciences	9	9	512
4	Health Sciences	6	6	2.1K
5	Public Health	3	3	159

Michael A. Palladino

137

Publications

20.1K

Citations

H-Index

Page 1

	Year	Citations
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin Diane Pennica, Glenn E. Nedwin, Joel S. Hayflick, Nature InflammationImmunotoxicologyPathogenesisImmunologyNecrosis Factor	1984	1.7K
Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro Barry J. Sugarman, Bharat B. Aggarwal, Philip E. Hass, Science ApoptosisImmune RegulationImmunologyCell DeathPathology	1985	1.6K
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. C A Dinarello, Joseph G. Cannon, S. M. Wolff, The Journal of Experimental Medicine ImmunologyImmune RegulationPathologyCell DeathImmunologic Mechanism	1986	1.5K
Activation of human polymorphonuclear neutrophil functions by interferon-<i>gamma</i> and tumor necrosis factors. M R Shalaby, B B Aggarwal, Emily Rinderknecht, The Journal of Immunology	1985	913
The two different receptors for tumor necrosis factor mediate distinct cellular responses. Louis A. Tartaglia, R F Weber, Irene S. Figari, Proceedings of the National Academy of Sciences Human TnfImmunologyImmune RegulationCell DeathPathology	1991	813
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib Dharminder Chauhan, Laurence Catley, Guilan Li, Cancer Cell Hematological MalignancyMedicineApoptosisImmunologyPharmacology	2005	695
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity Patrick W. Gray, Bharat B. Aggarwal, Charles V. Benton, Nature Autoimmune DiseaseImmunotoxicologyImmunologyCell DeathPathology	1984	635
Cytokine appearance in human endotoxemia and primate bacteremia. David G. Hesse, Kevin J. Tracey, Yuman Fong, PubMed InflammationCytokineMicrobial PathogensBacterial InfusionLive Escherichia Coli	1988	537
Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. Gerald Ranges, I S Figari, Terje Espevik, The Journal of Experimental Medicine Lymphocyte DevelopmentT-regulatory CellImmunologyCell DeathPathology	1987	494
Effect of interleukin 2, interferon-<i>gamma</i>, and mitogens on the production of tumor necrosis factors <i>alpha</i> and <i>beta</i>. Glenn E. Nedwin, L P Svedersky, Timothy S. Bringman, The Journal of Immunology	1985	489

Page 1